Nevertheless, the overexpression of FAP and thus the presence of large quantities of CAFs (20%–40% of total tumor mass) in 28 common tumors including breast, colorectal, pancreatic, and lung suggests that treatments targeting FAP may have broad applications for solid tumors [37]. Here, FAP is linked to neoplasm.